Navigation Links
VIA Pharmaceuticals Featured at Cambridge Healthtech Institute Discovery on Target 2009 Conference
Date:10/29/2009

loan from Bay City Capital;
  • our ability to timely recruit and enroll patients in any future clinical trials;
  • our failure to obtain sufficient data from enrolled patients that can be used to evaluate VIA-2291, thereby impairing the validity or statistical significance of our clinical trials;
  • our ability to successfully complete our clinical trials of VIA-2291 on expected timetables and the outcomes of such clinical trials;
  • complexities in designing and implementing cardiometabolic clinical trials using surrogate endpoints in Phase 1 and Phase 2 clinical trials which may differ from the ultimate endpoints required for registration of a candidate drug;
  • the results of our clinical trials, including without limitation, with respect to the safety and efficacy of VIA-2291;
  • if the results of the ACS and CEA studies, upon further review and analysis, are revised, interpreted differently by regulatory authorities or negated by later stage clinical trials;
  • our ability to obtain necessary FDA approvals, including to initiate future clinical trials of VIA-2291;
  • our ability to successfully commercialize VIA-2291;
  • our ability to identify potential clinical candidates from the family of DGAT1 compounds licensed and move them into preclinical development;
  • our ability to obtain and protect our intellectual property related to our product candidates;
  • our potential for future growth and the development of our product pipeline, including the THR beta agonist candidate and the other compounds licensed from Roche;
  • our ability to obtain strategic opportunities to partner and collaborate with large biotechnology or pharmaceutical companies to further develop VIA-2291;
  • our ability to form and maintain collaborative relationships to develop and commercialize our product candidates;
  • general economic and business conditions; and
  • the other risks described under Item 1A "Risk
    '/>"/>

  • SOURCE VIA Pharmaceuticals, Inc.
    Copyright©2009 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5

    Related medicine news :

    1. Vanda Pharmaceuticals to Announce Third Quarter 2009 Financial Results on November 2, 2009
    2. Amira Pharmaceuticals to Present at the BIO Investor Forum in San Francisco
    3. Positive Data from Arena Pharmaceuticals Pivotal BLOOM Trial Demonstrate that Lorcaserin Significantly Improved Markers of Cardiovascular Risk and Glycemic Parameters and was not Associated with Depression or Suicidal Ideation
    4. DUSA Pharmaceuticals Named to Deloittes 2009 Technology Fast 500 List of Fastest Growing Companies in North America
    5. Peregrine Pharmaceuticals Announces Implementation of 1:5 Reverse Stock Split to Take Effect October 19, 2009
    6. Proteolix, Inc. to be Acquired By Onyx Pharmaceuticals
    7. Amira Pharmaceuticals to Present at Montgomery Healthcare Conference
    8. Cadence Pharmaceuticals CEO Ted Schroeder to Present at the JMP Securities Healthcare Focus Conference in New York on October 6, 2009
    9. Onyx Pharmaceuticals to Host Investor Briefing Following ECCO/ESMO Oncology Congress
    10. Biostar Pharmaceuticals, Inc. to Present at the Maxim Group Growth Conference on September 29 at 2:00pm ET
    11. DUSA Pharmaceuticals to Present at the Maxim Group 3rd Annual Growth Conference
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:8/30/2014)... 30, 2014 Daily Gossip magazine reveals ... anxiety and panic attacks under control with a simple ... review describes this new method as an anxiety ... attacks and overcome general anxiety related disorders. , ... the fact that it can be accessed by users ...
    (Date:8/30/2014)... (PRWEB) August 30, 2014 The ... Nutrition and Pharameuticals. Nutraceuticals is a source of ... ingredients from natural food sources. Nutraceutical ingredients have ... to the human body. Nutraceutical health products include ... fortified foods and more. Although nature is the ...
    (Date:8/30/2014)... NY (PRWEB) August 30, 2014 ... throughout the planet has been one of the ... order to create a positive impact around the ... and staffed with top trained executives and trainers ... of people worldwide. Vital statistics demonstrate that ...
    (Date:8/30/2014)... 2014 Market Research Report on ... a professional and in-depth market survey on Global ... reviews the basic information of Cell Disruptor including ... then explores global and China’s top manufacturers of ... value, and market share etc. The report further ...
    (Date:8/30/2014)... Beach, Calif. (PRWEB) August 30, 2014 Insomnia ... Francis helps listeners understand how they unknowingly developed insomnia and ... have restful nights during. Tune in to the show ... The show airs live on August 30, and will ... more information on programming, go to DrCarolFrancisTalkRadio.com. , ...
    Breaking Medicine News(10 mins):Health News:Panic Away Review Reveals New Natural Remedy for Anxiety Patients 2Health News:A Granular Analysis of the Nutraceutical Ingredients Market by Transparency Market Research 2Health News:A Granular Analysis of the Nutraceutical Ingredients Market by Transparency Market Research 3Health News:A Granular Analysis of the Nutraceutical Ingredients Market by Transparency Market Research 4Health News:Cradle of Aviation Museum Opens Its Doors to Long Island Scientologists 2Health News:Cell Disruptor Industry Global and Chinese Analysis for 2009-2019 in New Research Report at ReportsnReports.com 2Health News:Cell Disruptor Industry Global and Chinese Analysis for 2009-2019 in New Research Report at ReportsnReports.com 3Health News:Cell Disruptor Industry Global and Chinese Analysis for 2009-2019 in New Research Report at ReportsnReports.com 4Health News:Sleepless Nights, Exhausting Days, Mental Fog – Relief for Insomnia With Clinical Psychologist Dr. Carol Francis 2
    ... and his team from Southampton General Hospital, studied the ... research work is aimed at studying the environmental risk ... to metal fume. ,Researchers found that the ... compared to the normal persons and an absence of ...
    ... has a profound effect on your health status. Confirming ... Massachusetts// and Pennsylvania which shows that race/ethnicity is a ... HAART (highly active antiretroviral therapy). , ,The study ... AIDS Clinical Trial Group studies. The main thrust was ...
    ... Pakistan appears to be in serious trouble with regard to ... country, bringing to a halt, an eight-year-old health program for ... the Lahore-based // NGO Vision that operates the Nayab Health ... and transgenders. ,Helped by Britain's Naz Foundation International, ...
    ... bowel movements, abdominal pain, and the Irritable Bowel Syndrome (IBS) ... China and India. Prof Jianping Liu, lead review author, said ... that some of the traditional medicines did improve the global ... were conducted on a small scale, so it is reported ...
    ... Unhappy marriages are harmful to the self-esteem and health of ... to higher levels of psychological distress when compared to those ... as many as 1,150 people in unhappy // marriages ... of sociology, human development and family studies, and demography said ...
    ... fertility predictor test, which enables women to find out ... This will be particularly useful to women who prefer ... for child bearing is// reported to be the twenties ... Sheffield University. But the pressure of modern life is ...
    Cached Medicine News:Health News:Pakistani Gays Land Themselves In Trouble 2
    (Date:8/29/2014)... , Aug. 29, 2014   Vittamed Corporation , ... announced today that T. (Teo) Forcht Dagi ... the company,s Board of Directors. " Teo ... career in neurosurgery, medical innovation and venture capital," said ... extremely delighted to add his clinical, strategic, and entrepreneurial expertise ...
    (Date:8/29/2014)... Aug. 29, 2014 /PRNewswire-iReach/ -- ChemImage will present a ... and New Zealand Forensic Science Society,s 22 nd ... Adelaide, Australia .  Forensic Scientists ... advancements that hyperspectral imaging can bring to examination ... , Director of Product Development at ChemImage, will ...
    (Date:8/29/2014)... PASO ROBLES, Calif. , Aug. 29, 2014 /PRNewswire/ ... launch of its new website design . The ... an overhaul that showcases the company,s new services and ... By implementing a new streamlined design, viewers can ... deliver metrics for health care practices and create a ...
    Breaking Medicine Technology:Vittamed Adds Prominent Neurosurgeon and Venture Capitalist T. Forcht Dagi to Board of Directors 2ChemImage to Discuss Hyperspectral Imaging for Forensic Investigation at the ANZFSS 22nd International Symposium on the Forensic Sciences 2ChemImage to Discuss Hyperspectral Imaging for Forensic Investigation at the ANZFSS 22nd International Symposium on the Forensic Sciences 3PMDS Announces New Website 2
    ... SAN DIEGO, Dec. 21, 2010 Arena Pharmaceuticals, Inc. (Nasdaq: ... President and Chief Executive Officer, will host a conference call ... Eastern Time (5:30 a.m. Pacific Time) to provide an update ... Food and Drug Administration (FDA) for the lorcaserin New Drug ...
    ... YORK, Dec. 21, 2010 Reportlinker.com announces that ... its catalogue: U.S. Preclinical ... http://www.reportlinker.com/p0350308/US-Preclinical-Animal-Imaging-Systems-Market.html This research ... Animal Imaging Systems Market since 2006. It examines ...
    Cached Medicine Technology:Arena Pharmaceuticals to Host Conference Call and Webcast to Provide Update Following Lorcaserin End-of-Review Meeting With FDA 2Arena Pharmaceuticals to Host Conference Call and Webcast to Provide Update Following Lorcaserin End-of-Review Meeting With FDA 3
    Inquire...
    ... injection of contrast medium, anesthetic gel, and/or ... eliminates the need for multiple catheterizations. The ... passage into and through the ureter. AQ ... that when activated, attracts and holds water ...
    Used for retrograde pyelogram. Supplied sterile in peel-open packages. Intended for one-time use....
    Used for the retrieval of stones, stents, or other objects in the urinary tract under direct vision. Retrieval Forceps are designed for use through rigid or flexible endoscopes. Supplied sterile in p...
    Medicine Products: